Michael Leviten
Nanoscience and Nanotechnology
PX Biosolutions
Australia
Biography
Michael joined BioCentury in April 2016 as a senior writer for BioCentury Innovations. He brings with him 18 years of experience as an R&D scientist at biotech companies Deltagen Inc., Bayhill Therapeutics Inc. and Annexon Inc., where he focused on the development of biologic therapies for autoimmune and neurodegenerative diseases.
Research Interest
Nanoscience and Nanotechnology
